8-K filed Feb 10, 2026
Zimmer Biomet authorizes $1.5B for stock buybacks
“Additionally, on February 9, 2026, Zimmer Biomet's Board of Directors approved a new stock repurchase authorization, granting the Company authority to repurchase up to $1.5 billion in common stock.”
From Zimmer Biomet’s 8-K filed Feb 10, 2026 · read the filing · all documents
How big is it?
Zimmer Biomet bought back $751M of stock in the twelve months to Jun 30, 2026. At that pace, $1.5B covers about 2.0 years of buybacks.
The amount equals 98% of its free cash flow over the same twelve months ($1.5B).
Its diluted share count is down 2.8% from a year earlier.
An authorization is permission, not a promise: the company can buy less, more slowly, or not at all, and usually doesn't have to say when it buys.
Show as table
| Period | Value |
|---|---|
| Q3 '23 | $0 |
| Q4 '23 | $410.3M |
| Q1 '24 | $113.6M |
| Q2 '24 | $85.9M |
| Q3 '24 | $596.3M |
| Q4 '24 | $72.2M |
| Q1 '25 | $229.8M |
| Q2 '25 | $7.2M |
| Q3 '25 | $0 |
| Q4 '25 | $250M |
| Q1 '26 | $250.1M |
| Q2 '26 | $250.7M |